Search Results - "Zumsteg, Zachary S."

Evolution of the Oropharynx Cancer Epidemic in the United States: Moderation of Increasing Incidence in Younger Individuals and Shift in the Burden to Older Individuals by Tota, Joseph E, Best, Ana F, Zumsteg, Zachary S, Gillison, Maura L, Rosenberg, Philip S, Chaturvedi, Anil K

“…Human papillomavirus-positive oropharynx cancer incidence has increased rapidly in cohorts of US white men born during the 1930s to 1950s. It is unknown how…”
Get full text

Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer by Ho, Allen S, Kim, Sungjin, Tighiouart, Mourad, Gudino, Cynthia, Mita, Alain, Scher, Kevin S, Laury, Anna, Prasad, Ravi, Shiao, Stephen L, Van Eyk, Jennifer E, Zumsteg, Zachary S

“…Purpose Current staging systems for oral cavity cancers incorporate lymph node (LN) size and laterality, but place less weight on the total number of positive…”
Get full text

Stereotactic Body Radiation Therapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies by Jackson, William C., Silva, Jessica, Hartman, Holly E., Dess, Robert T., Kishan, Amar U., Beeler, Whitney H., Gharzai, Laila A., Jaworski, Elizabeth M., Mehra, Rohit, Hearn, Jason W.D., Morgan, Todd M., Salami, Simpa S., Cooperberg, Matthew R., Mahal, Brandon A., Soni, Payal D., Kaffenberger, Samuel, Nguyen, Paul L., Desai, Neil, Feng, Felix Y., Zumsteg, Zachary S., Spratt, Daniel E.

“…Utilization of stereotactic body radiation therapy (SBRT) for treatment of localized prostate cancer is increasing. Guidelines and payers variably support the…”
Get full text

Commensal bacteria and fungi differentially regulate tumor responses to radiation therapy by Shiao, Stephen L., Kershaw, Kathleen M., Limon, Jose J., You, Sungyong, Yoon, Junhee, Ko, Emily Y., Guarnerio, Jlenia, Potdar, Alka A., McGovern, Dermot P.B., Bose, Shikha, Dar, Tahir B., Noe, Paul, Lee, Jung, Kubota, Yuzu, Maymi, Viviana I., Davis, Madison J., Henson, Regina M., Choi, Rachel Y., Yang, Wensha, Tang, Jie, Gargus, Matthew, Prince, Alexander D., Zumsteg, Zachary S., Underhill, David M.

“…Studies suggest that the efficacy of cancer chemotherapy and immunotherapy is influenced by intestinal bacteria. However, the influence of the microbiome on…”
Get full text

Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis by Sroussi, Herve Y, Epstein, Joel B., Bensadoun, Rene‐Jean, Saunders, Deborah P., Lalla, Rajesh V., Migliorati, Cesar A., Heaivilin, Natalie, Zumsteg, Zachary S.

“…Patients undergoing radiation therapy for the head and neck are susceptible to a significant and often abrupt deterioration in their oral health. The oral…”
Get full text

Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality by Spratt, Daniel E, Zhang, Chi, Zumsteg, Zachary S, Pei, Xin, Zhang, Zhigang, Zelefsky, Michael J

“…Abstract Background In vitro data and early clinical results suggest that metformin has desirable antineoplastic effects and has a theoretical benefit on…”
Get full text

The Natural History and Predictors of Outcome Following Biochemical Relapse in the Dose Escalation Era for Prostate Cancer Patients Undergoing Definitive External Beam Radiotherapy by Zumsteg, Zachary S, Spratt, Daniel E, Romesser, Paul B, Pei, Xin, Zhang, Zhigang, Polkinghorn, William, McBride, Sean, Kollmeier, Marisa, Yamada, Yoshiya, Zelefsky, Michael J

“…Abstract Background The management of biochemical failure (BF) following external beam radiotherapy (EBRT) for prostate cancer is controversial, due to both…”
Get full text

Comparison of high‐dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate‐risk prostate cancer by Spratt, Daniel E., Zumsteg, Zachary S., Ghadjar, Pirus, Kollmeier, Marisa A., Pei, Xin, Cohen, Gilad, Polkinghorn, William, Yamada, Yoshiya, Zelefsky, Michael J.

“…Objective To compare tumour control and toxicity outcomes with the use of high‐dose intensity‐modulated radiation therapy (IMRT) alone or brachytherapy…”
Get full text

Interplay and cooperation between SREBF1 and master transcription factors regulate lipid metabolism and tumor-promoting pathways in squamous cancer by Li, Li-Yan, Yang, Qian, Jiang, Yan-Yi, Yang, Wei, Jiang, Yuan, Li, Xiang, Hazawa, Masaharu, Zhou, Bo, Huang, Guo-Wei, Xu, Xiu-E, Gery, Sigal, Zhang, Ying, Ding, Ling-Wen, Ho, Allen S., Zumsteg, Zachary S., Wang, Ming-Rong, Fullwood, Melissa J., Freedland, Stephen J., Meltzer, Stephen J., Xu, Li-Yan, Li, En-Min, Koeffler, H. Phillip, Lin, De-Chen

“…Squamous cell carcinomas (SCCs) comprise one of the most common histologic types of human cancer. Transcriptional dysregulation of SCC cells is orchestrated by…”
Get full text

Translational and clinical implications of the genetic landscape of prostate cancer by Spratt, Daniel E., Zumsteg, Zachary S., Feng, Felix Y., Tomlins, Scott A.

“…Key Points Investigations of the genomic landscape of primary and metastatic castration-resistant prostate cancer have provided fundamental insights into the…”
Get full text

Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival by Abugharib, Ahmed, Jackson, William C, Tumati, Vasu, Dess, Robert T, Lee, Jae Y, Zhao, Shuang G, Soliman, Moaaz, Zumsteg, Zachary S, Mehra, Rohit, Feng, Felix Y, Morgan, Todd M, Desai, Neil, Spratt, Daniel E

“…Purpose Early salvage radiotherapy following radical prostatectomy for prostate cancer is commonly advocated in place of adjuvant radiotherapy. We aimed to…”
Get full text

Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care? by Zumsteg, Zachary S, MD, Zelefsky, Michael J, Prof

“…Summary What is the best way to manage patients with intermediate-risk prostate cancer? One of the most controversial aspects of treatment is the role of…”
Get full text

The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment by Maggiore, Ronald, MD, Zumsteg, Zachary S., MD, BrintzenhofeSzoc, Karlynn, PhD, MSW, Trevino, Kelly M., PhD, Gajra, Ajeet, MD, Korc-Grodzicki, Beatriz, MD, PhD, Epstein, Joel B., DMD, MSD, Bond, Stewart M., PhD, RN, AOCN, Parker, Ira, DDS, MA, MPH, Kish, Julie A., MD, Murphy, Barbara A., MD, VanderWalde, Noam A., MD

“…Older adults with head and neck squamous cell carcinoma (HNSCC) pose unique treatment and supportive care challenges to oncologists and other cancer care…”
Get full text

Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma by Zumsteg, Zachary S, Riaz, Nadeem, Jaffery, Sana, Hu, Man, Gelblum, Daphna, Zhou, Ying, Mychalczak, Borys, Zelefsky, Michael J, Wolden, Suzanne, Rao, Shyam, Lee, Nancy Y

“…Summary Background Although intensity-modulated radiotherapy (IMRT) is a standard of care for many head and neck cancers, its use for carotid-sparing (CS)…”
Get full text

Short-term Androgen-Deprivation Therapy Improves Prostate Cancer-Specific Mortality in Intermediate-Risk Prostate Cancer Patients Undergoing Dose-Escalated External Beam Radiation Therapy by Zumsteg, Zachary S., MD, Spratt, Daniel E., MD, Pei, Xin, PhD, Yamada, Yoshiya, MD, Kalikstein, Abraham, BS, Kuk, Deborah, MS, Zhang, Zhigang, PhD, Zelefsky, Michael J., MD

“…Purpose We investigated the benefit of short-term androgen-deprivation therapy (ADT) in patients with intermediate-risk prostate cancer (PC) receiving…”
Get full text

Predictors of survival in head and neck mucosal melanoma by Schmidt, Matthew Q., David, John, Yoshida, Emi J., Scher, Kevin, Mita, Alain, Shiao, Stephen L., Ho, Allen S., Zumsteg, Zachary S.

“…•This is the largest study of head and neck mucosal melanomas to date.•Prognosis remains poor with a 27.9% 5-year overall survival.•Paranasal sinus tumors have…”
Get full text

Survival Impact of Adjuvant Therapy in Salivary Gland Cancers following Resection and Neck Dissection by Aro, Katri, Ho, Allen S., Luu, Michael, Kim, Sungjin, Tighiouart, Mourad, Yoshida, Emi J., Mallen-St Clair, Jon, Shiao, Stephen L., Leivo, Ilmo, Zumsteg, Zachary S.

“…Objective To evaluate the impact of postoperative radiotherapy (PORT) and chemotherapy on survival in salivary gland cancer (SGC) treated with curative-intent…”
Get full text

Combined high‐intensity local treatment and systemic therapy in metastatic head and neck squamous cell carcinoma: An analysis of the National Cancer Data Base by Zumsteg, Zachary S., Luu, Michael, Yoshida, Emi J., Kim, Sungjin, Tighiouart, Mourad, David, John M., Shiao, Stephen L., Mita, Alain C., Scher, Kevin S., Sherman, Eric J., Lee, Nancy Y., Ho, Allen S.

“…BACKGROUND There is increasing evidence that primary tumor ablation can improve survival for some cancer patients with distant metastases. This may be…”
Get full text

Stage I HPV‐positive oropharyngeal cancer: Should all patients receive similar treatments? by Yoshida, Emi J., Luu, Michael, Mallen‐St. Clair, Jon, Mita, Alain C., Scher, Kevin S., Lu, Diana J., Nguyen, Anthony T., Shiao, Stephen L., Ho, Allen S., Zumsteg, Zachary S.

“…Background Patients with clinical stage I human papillomavirus (HPV)–positive oropharyngeal squamous cell cancer (OPSCC) according to the American Joint…”
Get full text

Simultaneous Integrated Micro-boost: Reigniting the FLAME for Dose Escalation in Prostate Cancer? by Zumsteg, Zachary S.

Get full text